I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy: Isikhokelo esiBanzi 

I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy yindlela entsha yonyango lomhlaza edibanisa utyando olungephi kunye ne-chemoimmunotherapy eyenzelwe umntu isiwe ngqo kwithumba. Le ndlela ijolise ekwandiseni ukusebenza kakuhle kwonyango ngelixa kuncitshiswa iziphumo ebezingalindelekanga, ezinokukhokelela kwiziphumo eziphuculweyo zesigulane. Eli nqaku ligocagoca kwiinkcukacha zobu buchule, kubandakanywa nemigaqo, iinkqubo, iinzuzo, kunye nezikhokelo zexesha elizayo.

Ukuqonda Intratumoral Chemoimmunotherapy

I-Intratumoral chemoimmunotherapy ibandakanya ukutofa ngokuthe ngqo i-chemotherapeutic agents kunye / okanye i-immunotherapeutic agents kwi-tumor. Olu nikezelo lwasekhaya luvumela ugxininiso oluphezulu lwechiza ukufikelela kwindawo yethumba, ukunciphisa ukuvezwa kwenkqubo kunye netyhefu xa kuthelekiswa nechemotherapy yendabuko emithanjeni. Ihlala isetyenziswa kunye nolunye unyango olufana notyando okanye unyango lwemitha.

I-Evolution yoNyango loMhlaza

Unyango lwesintu lomhlaza, olufana ne-systemic chemotherapy kunye nonyango lwemitha, luhlala luchaphazela wonke umzimba, lukhokelela kwiziphumo ebezingalindelekanga ezibalulekileyo. Unyango lwe-Intratumoral lumele utshintsho olubhekiselele kwiindlela ezijoliswe ngakumbi kunye nezomntu ngamnye. Ngokugxila kunyango ngokuthe ngqo kwi-tumor, ijolise ekukhuseleni izicubu eziphilileyo kunye nokuphucula umgangatho wobomi besigulane. IZiko loPhando ngoMhlaza laseShandong Baofa uzibophelele ekuveliseni izinto ezintsha kulo mmandla.

Indlela ye ‘Ultra-Minimum Incision’

Inkalo ye-'Ultra-Minimum Minimum Incision' ibhekisa kubuchule botyando obusetyenziswayo ukufikelela kwithumba lokutofwa. Oku kudla ngokubandakanya ukusika okuncinci, okuhlala kukhokelwa buchwephesha bemifanekiso efana ne-ultrasound okanye i-CT scans, ukuqinisekisa ukuhanjiswa okuchanekileyo kweearhente zonyango. Ubume obuncinci benkqubo bunegalelo kwixesha lokubuyisela ngokukhawuleza kunye nokunciphisa intlungu emva kokuhlinzwa.

Izibonelelo zoTyando oluHlangeneyo kancinci

• Amanxeba amancinci
• Iintlungu ezincinci
• Ukuhlala ixeshana esibhedlele
• Ukuchacha ngokukhawuleza
• Ukunciphisa umngcipheko weengxaki

I-Chemoimmunotherapy yoMntu: Ukulungelelanisa unyango kumntu ngamnye

Ukwenza umntu kube yinto ephambili yale ndlela. Ngaphambi konyango, i-tumor yesigulane ihlalutywa ukuchonga iimpawu zayo ezithile, ezifana nokuguqulwa kofuzo kunye namanqaku okuzivikela omzimba. Olu lwazi ke lusetyenziswa ukukhetha eyona arhente chemotherapeutic kunye immunotherapeutic ukuba ithumba ethile. Le ndlela yokwenziwa komntu ikhulisa amathuba okuphumelela unyango kwaye inciphisa umngcipheko wokusabela okubi.

Indima yoHlahlelo lweBiomarker

Uhlalutyo lwe-Biomarker lubalulekile kunyango lwe-chemoimmunotherapy. Ngokuchonga ii-biomarkers ezithile kwithumba, oogqirha banokuqikelela ukuba ngawaphi amachiza anokuthi asebenze. Ngokomzekelo, intetho ye-PD-L1 ingabonisa ukusabela okunokwenzeka kwii-immunotherapies ezithile.

Inkqubo: Inyathelo ngeNyathelo

I I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy Inkqubo ibandakanya la manyathelo alandelayo:

1. Uvavanyo lwangaphambili: Isigulana sivavanywa ngokucokisekileyo, kubandakanywa izifundo zokucinga kunye nohlalutyo lwe-biomarker.
2. Isicwangciso sonyango: Ngokusekelwe kuvavanyo, isicwangciso sonyango lomntu siqu siphuhlisiwe, sichaza i-chemotherapeutic kunye ne-immunotherapeutic agents eziza kusetyenziswa.
3. Inkqubo: Isigulana sifumana inkqubo encinci yokuhlasela, ngexesha apho amachiza atofwa ngokuthe ngqo kwithumba phantsi kwesikhokelo somfanekiso.
4. Ukubeka iliso emva kokusebenza: Isigulane sibekwe esweni ngokusondeleyo nayiphi na imiphumo emibi okanye iingxaki. Izifundo zokulandela umzobo zenziwa ukuvavanya impendulo kunyango.

IiNzuzo ezinokubakho ze I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy

Le ndlela intsha ibonelela ngeenzuzo ezininzi ezinokubakho xa kuthelekiswa nonyango lwesintu lomhlaza:

• Ukusebenza okuphuculweyo: Uxinzelelo oluphezulu lweziyobisi kwindawo ye-tumor.
• Ityhefu eyehlisiwe: Ukuvezwa okuphantsi kwenkqubo ye-chemotherapy.
• Unyango olulolwakho: Ilungelelaniswe kwiimpawu ze-tumor zesigulana ngasinye.
• Iyahlasela kancinci: Ukuchacha ngokukhawuleza kunye neentlungu ezincinci.
• Amandla okuvuselela amajoni omzimba: Ukuhanjiswa kwe-intratumoral ye-immunotherapeutic agents kunokuvuselela amajoni omzimba ukuba ahlasele i-tumor.

Imizekelo yeeCancers eziphathwa nge-Intratumoral Chemoimmunotherapy

Ngelixa uphando lusaqhubeka, I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ubonise isithembiso ekunyangeni iintlobo zomhlaza, kuquka:

• I-Melanoma
• Umhlaza wesibindi (Hepatocellular carcinoma)
• Umhlaza wamabele
• Umhlaza wemiphunga
• Amanye amathumba aqinileyo

Idatha yovavanyo lweklinikhi kunye noPhando

Ulingo oluninzi lwezonyango luyaqhuba ukuvavanya ukhuseleko kunye nokusebenza kakuhle kwe I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Iziphumo zakwangoko ziyathembisa, kunye nophononongo oluthile olubonisa ukwehla okukhulu kwethumba kunye nokuphuculwa kwamazinga okusinda kwizigulana eziphathwa ngale ndlela. Ngokomzekelo, uphando olupapashwe kwi Ijenali yeKlinikhi yeOncology Ubonise ukuphucuka okubalulekileyo kubomi bonke kwizigulana ezinemelanoma ephucukileyo enyangwa nge-intratumoral immunotherapy xa kuthelekiswa nezo zinyangwa nge-systemic chemotherapy. ^[1].

Ikamva le-Intratumoral Chemoimmunotherapy

Intsimi ye-intratumoral chemoimmunotherapy ikhula ngokukhawuleza. Imikhomba-ndlela yexesha elizayo iquka:

• Ukuphuhliswa kwe-chemotherapeutic kunye ne-immunotherapeutic agents ezintsha kunye nezisebenzayo.
• Iindlela eziphuculweyo zokwenza unyango lomntu olusekelwe kwiimpawu zethumba.
• Indibaniselwano yonyango lwe-intratumoral kunye nolunye unyango lomhlaza, olufana nonyango lwemitha kunye nonyango olujoliswe kuyo.
• Ukusetyenziswa kwe-nanotechnology ukuhambisa amachiza ngokuchanekileyo ngakumbi kwindawo ye-tumor.

Ukukhethwa kwesigulane kunye nokuqwalaselwa

Ayizizo zonke izigulane ezingabaviwa abafanelekileyo I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Izinto ekufuneka ziqwalaselwe ziquka:

• Ubungakanani bethumba kunye nendawo
• Impilo yesigulane iyonke
• Unyango lwangaphambili lomhlaza
• Ubukho bee-biomarkers ezithile

Ukuphononongwa ngokucokisekileyo liqela leengcali ezininzi ze-oncologists, oogqirha botyando kunye nezinye iingcali kubalulekile ukufumanisa ukuba le ndlela yonyango ifanelekile kwisigulane esithile. Izigulana ezifuna ulwazi oluthe kratya zamkelekile ukuba ziqhagamshelane nathi ukuze zibonwe okokuqala.

Imingcipheko enokubakho kunye neziphumo ebezingalindelekanga

Njengayo nayiphi na inkqubo yonyango, I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ithwala imingcipheko ethile kunye neziphumo ebezingalindelekanga. Oku kunokubandakanya:

• Iintlungu kunye nokudumba kwindawo yokutofa
• Usulelo
• Ukopha
• Ukwaliwa kumayeza
• Iziphumo ebezingalindelekanga zenkqubo yechemotherapy

Kubalulekile ukuxoxa ngezi ngozi kunye nogqirha wakho phambi kokuba ufumane unyango.

Iindleko kunye nokuFikelela

Iindleko ze I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy inokwahluka ngokuxhomekeka kumachiza athile asetyenzisiweyo, ubunzima benkqubo, kunye nendawo yeziko lonyango. Kubalulekile ukuxoxa ngeendleko kunye nomboneleli wakho wezempilo kunye nenkampani yeinshurensi. Ukufikeleleka kusenokuba ngumba, njengoko olu nyango lungekafumaneki ngokubanzi kuwo onke amaziko omhlaza.

Ukuqukumbela

I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy imele indlela entsha ethembisayo yonyango lomhlaza. Ngokudibanisa utyando olungephi kunye ne-chemoimmunotherapy yomntu, inika amandla okuphucula ukusebenza kakuhle, ukunciphisa ubuthi, kunye nokuphucula umgangatho wobomi besigulana. Ngelixa uphando olongezelelweyo lufunekayo, le ndlela yokuvuselela ithembisa kakhulu kwikamva lokhathalelo lomhlaza. Nge IZiko loPhando ngoMhlaza laseShandong Baofa, sihlala sizinikele ekuphuculeni ubuvulindlela kunyango lomhlaza kunye nokubonelela izigulana ngononophelo olungcono kakhulu. Qhagamshelana nathi ukuze ufunde ngakumbi malunga nokhetho lwethu olubanzi lonyango lomhlaza.

Iimbekiselo

[1] Ribas, A., et al. (2018). I-Intratumoral Immunotherapy. Ijenali yeKlinikhi yeOncology, 36(9), 919-927.